tldrdaily.news logo
Tag

Covid 19 Treatment

All articles tagged with #covid 19 treatment

health1 year ago

"Utah Clinic's Success in Treating Long COVID Patients"

Utah's Aspen Orthopedic Pain and Spine clinic is offering groundbreaking treatment for long COVID, with a focus on addressing the whole-body effects of the condition. The clinic provides Stellate Ganglion Block (SGB) treatment, which has shown promising results in alleviating symptoms such as loss of taste and smell. Dr. Greg Condie and his staff aim to help patients regain control of their lives and functionality, offering a holistic approach to long COVID treatment.

via KSL.com|
#aspen-orthopedic-pain-and-spine#covid-19-treatment#health
health-covid-191 year ago

"Paxlovid's Underuse Despite Ability to Reduce Severe COVID-19 Cases"

Paxlovid, an antiviral treatment for COVID-19, is proven to reduce the risk of severe illness and hospitalization, but it is underused due to high cost, doctors' hesitation to prescribe, and concerns about drug interactions. The drug was initially free but now has a list price of $1,390, making it inaccessible for many. Additionally, reimbursement rates and insurance coverage issues are hindering its availability. A study found that Paxlovid was disproportionately given to lower-risk patients, potentially preventing thousands of COVID-19 deaths if properly utilized.

via The Associated Press|
#covid-19-treatment#health-covid-19#hospitalization
health2 years ago

"Paxlovid: Understanding the Covid Treatment Option"

Paxlovid, an antiviral medication, has been found to significantly reduce the risk of death in high-risk Covid-19 patients. It consists of two medications that work together to stop the virus from replicating in the body. Anyone 12 or older who is considered high-risk, which includes a broad range of conditions, is a good candidate for Paxlovid. Despite its effectiveness, few people are taking the medication, possibly due to lack of awareness or concerns about potential rebound cases of Covid-19.

via The New York Times|
#antiviral-medication#covid-19-treatment#health
health2 years ago

Paxlovid: A Promising Covid Drug Despite Reduced Efficacy

A recent study published in JAMA Network Open found that Pfizer's antiviral Covid-19 treatment, Paxlovid, is 37% effective at preventing hospitalization or death in high-risk patients, significantly lower than the 88% effectiveness rate reported in clinical trials. However, the drug remains highly effective at preventing death, with an 84% effectiveness rate. The study analyzed real-world data from thousands of patients and also found that Merck's antiviral treatment, Lagevrio, was 42% effective in preventing hospitalization or death and 77% effective against death alone. The study authors noted that the differences in effectiveness could be attributed to factors such as the inclusion of vaccinated and previously infected patients and the presence of different Covid-19 variants. Despite the decrease in effectiveness, the authors still recommend the use of Paxlovid for high-risk patients to prevent severe outcomes.

via Forbes|
#covid-19-treatment#death#effectiveness
healthcare2 years ago

"Breaking: Exciting RX Product Updates Unveiled in September 2023"

In September 2023, several pharmaceutical products received FDA approval. Nirsevimab-alip (Beyfortus) by AstraZeneca is a monoclonal antibody that protects neonates and infants from respiratory syncytial virus (RSV). Remdesivir (Veklury) by Gilead Sciences is now approved for COVID-19 patients with severe renal impairment. Inclisiran (Leqvio) by Novartis received an expanded label to treat elevated LDL cholesterol in patients with comorbidities. Lecanemab-irmb (Leqembi) by Eisai Inc and Biogen Inc is now fully approved to treat Alzheimer's disease in patients with mild cognitive impairment or mild dementia.

via Pharmacy Times|
#alzheimers-disease#covid-19-treatment#fda-approval
health2 years ago

"Metformin: A Breakthrough Drug for Long COVID Treatment and Prevention"

A study conducted by the University of Minnesota has found that metformin, a commonly used diabetes drug, can prevent the development of long COVID. Participants taking metformin were over 40% less likely to develop long COVID, with a 63% reduction in risk if started within four days of symptom onset. The study involved over 1,200 overweight or obese participants aged 30-85. The researchers believe that metformin, being an inexpensive and widely available drug, could have significant public health implications as a preventive measure against long COVID.

via SciTechDaily|
#covid-19-treatment#diabetes-drug#health
legalcrime2 years ago

"Pfizer Insider Arrested for Trading on Secret COVID Treatment Information"

A former Pfizer employee and his friend have been arrested for insider trading after the ex-employee allegedly leaked confidential information about the successful clinical trials of Pfizer's COVID-19 treatment, Paxlovid, before it was publicly released. The employee purchased call options in Pfizer stock and informed his friend, leading to significant profits. Both individuals have been charged with securities fraud and conspiracy, with potential prison sentences of up to 20 years.

via USA TODAY|
#arrest#clinical-trials#covid-19-treatment
health2 years ago

Existing diabetes drug shows promise in reducing long COVID risk, study finds.

A clinical trial conducted by the University of Minnesota found that metformin, a drug commonly used to control blood sugar levels in individuals with Type 2 diabetes, could reduce the risk of long COVID by up to 63% if taken within three days of initial COVID diagnosis. The study involved over 1,300 participants and compared the effectiveness of metformin, ivermectin, and fluvoxamine to placebo therapy. Metformin was found to be consistent across diverse demographic populations and multiple viral variants, including the prevalent omicron variant. The drug is safe, low-cost, and widely available, making it a potential game-changer in the fight against long COVID.

via San Francisco Chronicle|
#clinical-trial#covid-19-treatment#diabetes
health2 years ago

Liver drug shows promise in reducing COVID-19 severity and infections.

A new study found that Paxlovid, an antiviral drug used to treat COVID-19, reduces the risk of long COVID by 26%. However, only 13% of eligible patients have received prescriptions for the drug due to various barriers, including healthcare disparities. The Biden Administration has purchased 20 million doses of Paxlovid, but when that supply runs out, pharmacies will start charging, leaving uninsured individuals to pay full price and those with insurance to pay a co-pay. Medicaid recipients will still receive Paxlovid for free through at least 2024, but some may lose coverage due to lifted pandemic-related requirements.

via Slate|
#access-to-healthcare#covid-19-treatment#health